These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 23429888)

  • 21. Structure of an agonist-bound human A2A adenosine receptor.
    Xu F; Wu H; Katritch V; Han GW; Jacobson KA; Gao ZG; Cherezov V; Stevens RC
    Science; 2011 Apr; 332(6027):322-7. PubMed ID: 21393508
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The 2.6 angstrom crystal structure of a human A2A adenosine receptor bound to an antagonist.
    Jaakola VP; Griffith MT; Hanson MA; Cherezov V; Chien EY; Lane JR; Ijzerman AP; Stevens RC
    Science; 2008 Nov; 322(5905):1211-7. PubMed ID: 18832607
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dynamic Role of the G Protein in Stabilizing the Active State of the Adenosine A
    Lee S; Nivedha AK; Tate CG; Vaidehi N
    Structure; 2019 Apr; 27(4):703-712.e3. PubMed ID: 30713025
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insights into adenosine A2A receptor activation through cooperative modulation of agonist and allosteric lipid interactions.
    Bruzzese A; Dalton JAR; Giraldo J
    PLoS Comput Biol; 2020 Apr; 16(4):e1007818. PubMed ID: 32298258
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of novel adenosine A(2A) receptor antagonists by virtual screening.
    Langmead CJ; Andrews SP; Congreve M; Errey JC; Hurrell E; Marshall FH; Mason JS; Richardson CM; Robertson N; Zhukov A; Weir M
    J Med Chem; 2012 Mar; 55(5):1904-9. PubMed ID: 22250781
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The second extracellular loop of GPCRs determines subtype-selectivity and controls efficacy as evidenced by loop exchange study at A2 adenosine receptors.
    Seibt BF; Schiedel AC; Thimm D; Hinz S; Sherbiny FF; Müller CE
    Biochem Pharmacol; 2013 May; 85(9):1317-29. PubMed ID: 23500543
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of novel thiazolo[5,4-d]pyrimidine derivatives as human A
    Varano F; Catarzi D; Falsini M; Vincenzi F; Pasquini S; Varani K; Colotta V
    Bioorg Med Chem; 2018 Jul; 26(12):3688-3695. PubMed ID: 29880250
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Crystal structure of the adenosine A
    Sun B; Bachhawat P; Chu ML; Wood M; Ceska T; Sands ZA; Mercier J; Lebon F; Kobilka TS; Kobilka BK
    Proc Natl Acad Sci U S A; 2017 Feb; 114(8):2066-2071. PubMed ID: 28167788
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An Affinity-Based Probe for the Human Adenosine A
    Yang X; Michiels TJM; de Jong C; Soethoudt M; Dekker N; Gordon E; van der Stelt M; Heitman LH; van der Es D; IJzerman AP
    J Med Chem; 2018 Sep; 61(17):7892-7901. PubMed ID: 30080404
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Communication over the network of binary switches regulates the activation of A2A adenosine receptor.
    Lee Y; Choi S; Hyeon C
    PLoS Comput Biol; 2015 Feb; 11(2):e1004044. PubMed ID: 25664580
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The crystallographic structure of the human adenosine A2A receptor in a high-affinity antagonist-bound state: implications for GPCR drug screening and design.
    Jaakola VP; Ijzerman AP
    Curr Opin Struct Biol; 2010 Aug; 20(4):401-14. PubMed ID: 20538452
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Limonene, a natural cyclic terpene, is an agonistic ligand for adenosine A(2A) receptors.
    Park HM; Lee JH; Yaoyao J; Jun HJ; Lee SJ
    Biochem Biophys Res Commun; 2011 Jan; 404(1):345-8. PubMed ID: 21134357
    [TBL] [Abstract][Full Text] [Related]  

  • 33. GPCR 3D homology models for ligand screening: lessons learned from blind predictions of adenosine A2a receptor complex.
    Katritch V; Rueda M; Lam PC; Yeager M; Abagyan R
    Proteins; 2010 Jan; 78(1):197-211. PubMed ID: 20063437
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structure of the adenosine A(2A) receptor bound to an engineered G protein.
    Carpenter B; Nehmé R; Warne T; Leslie AG; Tate CG
    Nature; 2016 Aug; 536(7614):104-7. PubMed ID: 27462812
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Validation of a Na
    Noël F; do Monte FM
    J Pharmacol Toxicol Methods; 2017; 84():51-56. PubMed ID: 27810394
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Binding Characterization of Agonists and Antagonists by MCCS: A Case Study from Adenosine A
    Cheng J; Chen M; Wang S; Liang T; Chen H; Chen CJ; Feng Z; Xie XQ
    ACS Chem Neurosci; 2021 May; 12(9):1606-1620. PubMed ID: 33856784
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antagonist binding and induced conformational dynamics of GPCR A2A adenosine receptor.
    Pang X; Yang M; Han K
    Proteins; 2013 Aug; 81(8):1399-410. PubMed ID: 23508898
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Statistics for the analysis of molecular dynamics simulations: providing P values for agonist-dependent GPCR activation.
    Bruzzese A; Dalton JAR; Giraldo J
    Sci Rep; 2020 Nov; 10(1):19942. PubMed ID: 33203907
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Simulation and Comparative Analysis of Different Binding Modes of Non-nucleoside Agonists at the A2A Adenosine Receptor.
    Dal Ben D; Buccioni M; Lambertucci C; Marucci G; Santinelli C; Spinaci A; Thomas A; Volpini R
    Mol Inform; 2016 Sep; 35(8-9):403-13. PubMed ID: 27546044
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thermostabilisation of an agonist-bound conformation of the human adenosine A(2A) receptor.
    Lebon G; Bennett K; Jazayeri A; Tate CG
    J Mol Biol; 2011 Jun; 409(3):298-310. PubMed ID: 21501622
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.